Skin News and Research

RSS

Team to execute research strategies surrounding oil spill health outcomes

While oil from the Deepwater Horizon spill may have stopped gushing into the Gulf of Mexico, experts are far from finished working to anticipate, outline and minimize the disaster's potential health risks, says a University of Alabama at Birmingham School of Public Health researcher actively involved in helping the federal government deal with repercussions from the April 20 accident.

31 Jul 2010

Resveratrol suppresses inflammation in humans: Research

Resveratrol, a popular plant extract shown to prolong life in yeast and lower animals due to its anti-inflammatory and antioxidant properties, appears also to suppress inflammation in humans, based on results from the first prospective human trial of the extract conducted by University at Buffalo endocrinologists.

31 Jul 2010

Epigenetic changes to DNA in breast cancers linked with environmental risk factors, tumor size: Study

Researchers from Brown University and the University of California San Francisco have found that epigenetic changes to DNA in breast cancers are related to environmental risk factors and tumor size, providing a window into the severity of the disease. The study is published in today's edition of PLoS Genetics. The researchers found that epigenetic profiles of tumors had a direct association with diet, alcohol, and tumor size.

31 Jul 2010

Despite all advancements in melanoma diagnosis, rapid treatment remains critical: Report

Twenty-five years after publishing the mnemonic "ABCD" to facilitate the early diagnosis of melanoma, the group who came up with that moniker says early detection remains a key factor in lowering mortality from malignant melanoma. Darrell S. Rigel, M.D. and colleagues from the Ronald O. Perelman Department of Dermatology at New York University School of Medicine say that, despite all of the advances in melanoma diagnosis, timely recognition, detection, and rapid treatment of melanoma remain critical.

30 Jul 2010

Intrinsic brain connectivity in fibromyalgia associated with chronic pain intensity

A recent study from researchers at Massachusetts General Hospital and University of Michigan provides the first direct evidence of linkage between elevated intrinsic (resting-state) brain connectivity and spontaneous pain intensity in patients with fibromyalgia (FM). This research shows an interaction of multiple brain networks, offering greater understanding of how pain arises. Details of the study appear online and in the August issue of Arthritis & Rheumatism, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology.

30 Jul 2010

Resveratrol suppresses inflammation and free radicals: Study

30 Jul 2010

Kiehl's Since 1851 inaugurates LifeRide to raise funds for amfAR

Maintaining its long-standing tradition of supporting HIV/AIDS charities, Kiehl's Since 1851, the venerable New York-based purveyor of fine quality skin and hair care, is pleased to announce a continued partnership with amfAR, The Foundation for AIDS Research.

30 Jul 2010

Life Time Fitness plans to open LifePower Yoga studio in Minnesota

Life Time Fitness, Inc. today announced plans to open its first LifePower Yoga studio in Minnesota. With a planned August 2010 opening, the new location will mark Life Time's 25th center in Minnesota, and its first dedicated solely to yoga and pilates. The company already operates two LifePower studios: LifePower at Pima Crossing, in Scottsdale, Arizona, and LifePower Phoenix.

30 Jul 2010

Anthera initiates PEARL-SC Phase 2b study of A-623 for lupus

Anthera Pharmaceuticals, Inc., a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced it has initiated PEARL-SC, the Phase 2b study of A-623, a novel inhibitor of B-Cell Activating Factor, or BAFF, for the treatment of Systemic Lupus Erythematosus (lupus). Lupus patients suffer from a chronic autoimmune disease, which often leads to severe skin rash, fatigue, joint pain, major organ complications, and cardiovascular disease.

30 Jul 2010

Shionogi's CUVPOSA receives FDA approval for treatment of chronic severe drooling

Shionogi Inc., a U.S.-based group company of Shionogi & Co., Ltd., today announced the U.S. Food and Drug Administration approval of CUVPOSA™ (glycopyrrolate), the first liquid treatment for patients ages 3-16 who suffer from chronic severe drooling associated with neurologic conditions such as cerebral palsy. CUVPOSA™ was designated an Orphan Drug by the FDA.

30 Jul 2010

Resting brain activity associated with spontaneous fibromyalgia pain

29 Jul 2010

Senate Commission presents 2010 list of MAK and BAT values containing new data on 61 substances

The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) Senate Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area has presented the 2010 list of MAK and BAT values containing new data on 61 substances. These values for the classification of health hazards constituted by work area substances have been adjusted this year.

29 Jul 2010

Safeguard Scientifics second-quarter aggregate revenue of partner companies increase 47% to $91.6 million

Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced that aggregate revenue of its partner companies for the three months ended June 30, 2010 was $91.6 million, up 47% from $62.3 million for the same partner companies in the same period of 2009. For the six months ended June 30, 2010, the aggregate partner company revenue was $176.9 million, up 45% from $121.8 million for the same partner companies for the same period of 2009.

29 Jul 2010

Intensive chemotherapy may benefit elderly patients with acute myeloid leukemia

The prognosis for nearly three-quarters of elderly patients on intensive chemotherapy for acute myeloid leukemia (AML) is poor, with a median survival of less than six months, according to a study published online today in Blood, the journal of the American Society of Hematology. AML is the most common form of acute leukemia among adults and is a rapidly growing cancer of the bone marrow that requires immediate treatment. The average age at diagnosis is 67, and more than 12,000 people will be diagnosed with AML this year (according to the National Cancer Institute).

29 Jul 2010

Scientists develop new surgical procedure for prostate cancer using natural orifices

With a recent first of its kind surgery, physicians at Mayo Clinic in Arizona have developed a new surgical procedure for the treatment of prostate cancer using natural orifices - signaling the next step in the evolution of minimally invasive surgery.

29 Jul 2010

Ten precautionary health tips for beachgoers, bathers

A yearlong beach study led by a team of University of Miami researchers suggests that swimmers at sub-tropical beaches face an increased risk of illness. The multi-disciplinary team examined the risk of illness that beachgoers face when exposed to recreational marine water at sub-tropical beaches with no known source of pollution or contamination.

29 Jul 2010

Price of sun overindulgence and tanning misuse is not just skin deep

It's what marketers lead us to believe is the picture of glowing health - the ultimate tan. But sun overindulgence and tanning misuse does have a price. And it's not just skin deep.

28 Jul 2010

Antares Pharma reports positive results from Anturol Gel Phase 3 study in overactive bladder patients

Antares Pharma, Inc. announced today positive results from its Phase 3 study of Anturol Gel in patients with overactive bladder. The study met its primary endpoint of a statistically significant reduction in urinary incontinence episodes for both doses studied.

28 Jul 2010

Research on method to open blood-brain barrier for safe cancer drug delivery

One of the human body's most powerful defensive tools, the blood-brain barrier is a chemical labyrinth that prevents toxins and viruses in the bloodstream from reaching the brain. This foolproof security system, however, limits the ability of physicians to deliver drugs directly to the brain, making it difficult to treat brain tumors. Researchers at Rensselaer Polytechnic Institute are endeavoring to solve this problem by investigating new methods for bypassing the blood-brain barrier and combating the spread of brain cancer.

28 Jul 2010

New partnership brings latest stem cell discoveries from laboratory to patient

A major research company affiliated with the University of Colorado with expertise in managing clinical trials is partnering with the University of Colorado's Anschutz Medical Campus to more efficiently bring the latest stem cell discoveries from the laboratory to the patient.

27 Jul 2010

Skin News and Research

Team to execute research strategies surrounding oil spill health outcomes

Resveratrol suppresses inflammation in humans: Research

Epigenetic changes to DNA in breast cancers linked with environmental risk factors, tumor size: Study

Despite all advancements in melanoma diagnosis, rapid treatment remains critical: Report

Intrinsic brain connectivity in fibromyalgia associated with chronic pain intensity

Resveratrol suppresses inflammation and free radicals: Study

Kiehl's Since 1851 inaugurates LifeRide to raise funds for amfAR

Life Time Fitness plans to open LifePower Yoga studio in Minnesota

Anthera initiates PEARL-SC Phase 2b study of A-623 for lupus

Shionogi's CUVPOSA receives FDA approval for treatment of chronic severe drooling

Resting brain activity associated with spontaneous fibromyalgia pain

Senate Commission presents 2010 list of MAK and BAT values containing new data on 61 substances

Safeguard Scientifics second-quarter aggregate revenue of partner companies increase 47% to $91.6 million

Intensive chemotherapy may benefit elderly patients with acute myeloid leukemia

Scientists develop new surgical procedure for prostate cancer using natural orifices

Ten precautionary health tips for beachgoers, bathers

Price of sun overindulgence and tanning misuse is not just skin deep

Antares Pharma reports positive results from Anturol Gel Phase 3 study in overactive bladder patients

Research on method to open blood-brain barrier for safe cancer drug delivery

New partnership brings latest stem cell discoveries from laboratory to patient

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News